StephanBusqueMD

Clinical Trials

• Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) Start of enrollment: 2005 Jun 01

  Completed

  Phase 4

• Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs Start of enrollment: 2004 Jul 01

  Active, not recruiting

  Phase 1, Phase 2

• Comparative Renal Function of Young (18-45 Years) and Ageing (55 Years and Above) Kidney Donors Start of enrollment: 2003 Mar 01

  Completed

• Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs. Start of enrollment: 2010 Jul 14

  Active, not recruiting

  Phase 1

• Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation Start of enrollment: 2017 Feb 14

  Recruiting

  Early Phase 1

  Roles: Principal Investigator

• TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation Start of enrollment: 2020 Feb 01

  Recruiting

  Phase 1

  Roles: Contact, Principal Investigator

• Delayed Blood Stem Transplantation in HLA Matched Kidney Transplant Recipients to Eliminate Immunosuppressive Drugs. Start of enrollment: 2018 Sep 13

  Recruiting

  Phase 1

  Roles: Principal Investigator, Contact, Sponsor-Investigator

• Islet Transplantation With Recipient T-Reg Cells or Deceased Donor Vertebral Bone Marrow Therapy Start of enrollment: 2023 Oct 01

  Not yet recruiting

  Phase 1

  Roles: Principal Investigator, Contact

• Join now to see all